Simon Tremblay, PharmD, PhD

Quick facts

Marketed products

• Mycophenolic Acid Oral Product · Immunology; Transplantation
  Mycophenolic acid inhibits inosine monophosphate dehydrogenase (IMPDH), selectively suppressing T and B lymphocyte proliferation to prevent organ rejection and autoimmune disease.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Simon Tremblay, PharmD, PhD portfolio CI brief
• Simon Tremblay, PharmD, PhD pipeline updates RSS